CI

Cowen Investment Management

North America, New York, United States, New York

Description

Cowen Investment Management was the asset management arm of Cowen Inc., a diversified financial services firm. Prior to Cowen Inc.'s acquisition by TD Bank Group in March 2023, Cowen Investment Management operated various alternative investment strategies, with a notable focus on sustainable solutions through its Cowen Sustainable Investments (CSI) group. CSI was dedicated to making private equity and credit investments in companies that provided innovative solutions addressing global sustainability challenges, spanning sectors such as renewable energy, sustainable agriculture, waste management, and energy efficiency.

TheThe Cowen Sustainable Investments group demonstrated its commitment to this niche by successfully closing its first dedicated private equity fund, Cowen Sustainable Investments Fund I, LP, in 2021, securing $300 million in capital commitments. This fund enabled CSI to pursue its strategy of investing in growth-stage companies and providing credit solutions. Their investment approach typically involved taking significant positions in companies poised for expansion, aiming to accelerate their impact and financial growth within the sustainable economy.

CSI's investment activities included both growth equity and private credit, targeting businesses with proven technologies and scalable models. For instance, in 2022, Cowen Sustainable Investments led a $20 million investment round in Arcadia, a technology company focused on renewable energy. While the specific check sizes varied depending on the deal structure and the stage of the company, their participation in such rounds suggests a focus on meaningful capital deployment to drive growth.

Following the acquisition of Cowen Inc. by TD Bank Group, the operations of Cowen Investment Management, including its sustainable investment initiatives, have been integrated into the broader TD enterprise, primarily under TD Cowen and TD Asset Management. While the direct investment activities under the "Cowen Investment Management" name may have evolved post-acquisition, its legacy as a direct investor in sustainable private equity and credit, supported by a $300 million fund, provides insight into its historical investment profile.

Investor Profile

Cowen Investment Management has backed more than 22 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 5% of its total and boasts 22 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series B, Post Ipo Debt rounds (top funding stages).
  • Majority of deals are located in United States, Canada, France.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Typical check size: $10M – $40M.

Stage Focus

  • Post Ipo Equity (64%)
  • Series B (9%)
  • Post Ipo Debt (9%)
  • Series A (5%)
  • Convertible Note (5%)
  • Series D (5%)
  • Series C (5%)

Country Focus

  • United States (82%)
  • Canada (9%)
  • France (5%)
  • United Kingdom (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Oncology
  • Genetics
  • Energy
  • Oil And Gas
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cowen Investment Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 2
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Jennison Associates
North America, New York, United States, New York
Co-Investments: 3
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 3

Which angels does Cowen Investment Management often collaborate with?

BN
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Cowen Investment Management?

LeddarTech

Quebec, Quebec, Canada

LeddarTech is an automotive solutions company that solves critical fusion and perception challenges for all levels of autonomy.

AutomotiveAutonomous VehiclesSoftwareSoftware Engineering
Series DFeb 3, 2022
Amount Raised: $116,000,000
erytech

Lyon, Rhone-Alpes, France

ERYtech Pharma is a biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.

BiopharmaBiotechnologyHealth CareMedicalOncology
Post Ipo EquitySep 21, 2020
G1 Therapeutics

Durham, North Carolina, United States

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.

BiotechnologyDeveloper PlatformMedicalOncologyTherapeutics
Post Ipo EquitySep 21, 2018
Amount Raised: $195,100,000
Allogene Therapeutics

South San Francisco, California, United States

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

BiotechnologyHealth DiagnosticsOncologyPharmaceutical
Convertible NoteSep 7, 2018
Amount Raised: $120,000,000
Spero Therapeutics

Cambridge, Massachusetts, United States

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

BiotechnologyMedical DeviceTherapeutics
Post Ipo EquityJul 17, 2018
Amount Raised: $75,000,000
Tellurian

Houston, Texas, United States

Tellurian is an oil and gas exploration and production company that trades liquefied natural gas cargoes globally.

EnergyOil and GasRetail
Post Ipo EquityJun 25, 2018
Amount Raised: $115,100,000
Canopy Growth

Smiths Falls, Ontario, Canada

Canopy Growth is a cannabis consumer product company that manufactures medical cannabis to improve lives.

CannabisHealth CareMedicalPharmaceutical
Post Ipo DebtJun 21, 2018
Amount Raised: $375,402,150
Boston Omaha

Omaha, Nebraska, United States

Boston Omaha operate three separate lines of business: outdoor billboards, surety insurance and related brokerage activities.

AdvertisingInsuranceReal Estate
Post Ipo EquityMar 20, 2018
Amount Raised: $76,890,000
Kura Oncology

La Jolla, California, United States

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

BiopharmaBiotechnologyGeneticsHealth CareMedicalOncologyPrecision Medicine
Post Ipo EquityMar 12, 2018
VirnetX

Zephyr Cove, Nevada, United States

VirnetX is an internet security software and technology company that provides technology for 4G long term evolution (LTE) security.

BlockchainCyber SecurityEnterprise SoftwareInformation TechnologyInternetSecuritySoftware
Post Ipo EquityMar 9, 2018
Amount Raised: $15,000,000